𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression of CD4+CD25highCD127low/− regulatory T cells in transitional cell carcinoma patients and its significance

✍ Scribed by Xi Zhu; Lin-Lin Ma; Tian Ye


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
144 KB
Volume
23
Category
Article
ISSN
0887-8013

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

To evaluate the expressions of CD4^+^CD25^high^CD127^low/−^ regulatory T cells (Tregs) in peripheral blood from patients with transitional cell carcinoma (TCC) in urinary system, we investigated the proportion of Treg population in CD4^+^ T from 93 patients with TCC, 38 with benign urinary diseases, and 37 healthy subjects by using flow cytometric analysis and analyzing different clinicopathologic characteristics and the changes before and after operation. We found that the proportion of Treg in peripheral blood from patients with TCC was significantly increased as compared with the othertwo groups. There was a strong correlation between the proportion of Treg and tumor recurrence, quantity, lymph node metastasis (P<0.01), as well as pathological stage; no correlation was found between the proportion of Treg and clinical TNM stage (P>0.05). The proportion of Treg was also different before and after operation (P<0.05). This suggest that CD4^+^CD25^+^CD127^low/−^ regulatory T cells may be responsible for immune suppression in TCC patients. The resection of tumor can decrease the proportion of Treg in peripheral blood. J. Clin. Lab. Anal. 23:197–201, 2009. © 2009 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Elevated frequencies of CD4+CD25+CD127lo
✍ Zhang Shenghui; Han Yixiang; Wu Jianbo; Yu Kang; Bi Laixi; Zhuang Yan; Xu Xi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 779 KB

## Abstract Regulatory T cells (Treg) mediate amelioration of disease and immune homeostasis by inhibiting immune activation and maintaining peripheral immune tolerance. The suppressive mechanisms and clinical significance of Treg have not been completely elucidated in patients with acute myeloid l

Serum IL10 and circulating CD4+CD25high
✍ Osama Alhamarneh; Frank Agada; Leigh Madden; Nicholas Stafford; John Greenman 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 934 KB

## Abstract ## Background. Patients with head and neck squamous cell carcinoma (HNSCC) commonly have an imbalance in T helper (Th)1/Th2‐type cytokines and elevated levels of CD4^+^CD25^high^ regulatory T cells (Treg). Here, we investigated the association of circulating interleukin (IL)10, IL12, a